Catapharma (India) Pvt Ltd, a active private limited company, was established on 29 October 1986 in Nashik, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U99999MH1986PTC041424. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.85 M.
It upholds a compliant status. Its leadership includes Manju Shrikant Karwa (Director), Shrikant Laxminarayan Karwa (Managing Director). Past directors included Pravin Shriram Marawar. It holds ₹4.55 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Catapharma House,S. No. 28/6/3, Ghadge Nagar Opp. Swimming Pool,Nashik Road, Nashik, Maharashtra, 422101.
U99999MH1986PTC041424
041424
29 October 1986
₹1.00 M
₹0.85 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Catapharma (India) Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Shrikant Karwa | Director | 18 Feb 2021 | Current |
| Shrikant Laxminarayan Karwa | Managing Director | 29 Oct 1986 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Catapharma (India) Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 120.68% increase. The company also saw a substantial improvement in profitability, with a 259.67% increase in profit. The company's net worth Soared by an impressive increase of 59.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Catapharma (India) had a public holding of 76.39%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹45,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2021 | Others | ₹2.00 Cr | Open |
| 23 Dec 1994 | Bank Of India | ₹2.45 Cr | Open |
| 27 Jun 1994 | Dena Bank | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Catapharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Catapharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catapharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Catapharma (India) Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Catapharma (India) Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge with Others amounted to Rs. 20.00 M with Charge ID 100440479 was registered on 23 Apr 2021. was recorded as a recent event.
Progress on Manju Shrikant Karwa was appointed as a Director was appointed as a Director on 18 Feb 2021 & has been associated with this company since 4 years 9 months . was documented.
Progress on A charge with Bank Of India amounted to Rs. 24.50 M with Charge ID 90375731 was registered on 23 Dec 1994. was documented.
A charge with Dena Bank amounted to Rs. 1.00 M with Charge ID 90375670 was registered on 27 Jun 1994. was recorded as a recent event.
The CIN of Catapharma (India) Pvt Ltd is U99999MH1986PTC041424.
Catapharma (India) Pvt Ltd is headquartered at Catapharma House,S. No. 28/6/3, Ghadge Nagar Opp. Swimming Pool,Nashik Road, Nashik, Maharashtra, 422101.
Catapharma (India) Pvt Ltd was incorporated on 29 October 1986.
The current directors of Catapharma (India) Pvt Ltd are
The primary industry of Catapharma (India) Pvt Ltd is Manufacturing.
Catapharma (India) Pvt Ltd is unlisted.
The authorized capital of Catapharma (India) Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹0.85 M.
The compliance status of Catapharma (India) Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX